Synaptics May Face Near-Term Headwinds Before Mass Production
Synaptics partners with Alphabet to develop edge AI products, enhancing IoT technology. See why I rate SYNA stock as a buy.
Electronic Products2 小时
Synaptics, Google partnership targets edge AI for the IoT
Synaptics and Google to advance edge AI for the IoT, leveraging Google’s ML core with Synaptics' Astra AI-Native computing ...
Synaptics Incorporated (NASDAQ:SYNA) Receives $97.33 Average Price Target from Analysts
Shares of Synaptics Incorporated (NASDAQ:SYNA – Get Free Report) have received an average rating of “Moderate Buy” from the nine brokerages that are currently covering the company, MarketBeat reports.
来自MSN7 小时
A New Approach to Neuromorphic Computing
The innovative MOSCap device integrates HfSe2 nanosheets, enabling neuron-like adaptive behavior and efficient memory ...
GlobalData on MSN7 小时
FDA grants ODD to NMD Pharma’s Charcot-Marie-Tooth disease therapy
The US FDA has granted ODD to NMD Pharma’s oral lead development programme, NMD670, designed to treat Charcot-Marie-Tooth disease (CMT).